BMRN — BioMarin Pharmaceutical Inc

Ownership history in Wilmington Savings Fund Society, FSB  ·  2 quarters on record

This page tracks every 13F SEC filing in which Wilmington Savings Fund Society, FSB reported a position in BioMarin Pharmaceutical Inc (BMRN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 8 +6 +300.0% 0.00% $433 $54.16
2024 Q3 INITIATED 2 — — 0.00% $141 $70.29
% of Fund (quarterly)    BMRN price (monthly, adj. close)

Other funds also holding BMRN

As of 2025 Q4 — sorted by position size

Krensavage Asset Management, LLC 3Y 7Y 11.02% BOONE CAPITAL MANAGEMENT LLC 3Y 7.68% Palo Alto Investors LP 3Y 7Y 6.17% Vestal Point Capital, LP 6.06% Eagle Health Investments LP 3Y 4.79% Novo Holdings A/S 3Y 7Y 3.05% Soleus Capital Management, L.P. 3Y 2.89% SECTOR GAMMA AS 3Y 7Y 2.69% Deep Track Capital, LP 3Y 2.44% Sio Capital Management, LLC 3Y 7Y 2.18%
← Back to Wilmington Savings Fund Society, FSB Holdings